Skip to Main Content

Author Details

H??l??ne Hovington
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
1999
35
17
PMIDPaper TitleJournal TitlePublished Year
36343786UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathways.Cancer Lett2023
37190147Leukocytic Infiltration of Intraductal Carcinoma of the Prostate: An Exploratory Study.Cancers (Basel)2023
37435060High infiltration of CD209<sup>+</sup> dendritic cells and CD163<sup>+</sup> macrophages in the peritumor area of prostate cancer is predictive of late adverse outcomes.Front Immunol2023
34259197Follicle-stimulating hormone (FSH) levels prior to prostatectomy are not related to long-term oncologic or cardiovascular outcomes for men with prostate cancer.Asian J Androl2022
35954173Uridine Diphosphate Glucuronosyl Transferase 2B28 (UGT2B28) Promotes Tumor Progression and Is Elevated in African American Prostate Cancer Patients.Cells2022
32676741Androgen receptor and immune cell PD-L1 expression in bladder tumors predicts disease recurrence and survival.World J Urol2021
34944863Identification of Morphologic Criteria Associated with Biochemical Recurrence in Intraductal Carcinoma of the Prostate.Cancers (Basel)2021
34743445Dimensional reduction based on peak fitting of Raman micro spectroscopy data improves detection of prostate cancer in tissue specimens.J Biomed Opt2021
32797086Identification of intraductal carcinoma of the prostate on tissue specimens using Raman micro-spectroscopy: A diagnostic accuracy case-control study with multicohort validation.PLoS Med2020
31932660GLUT1 expression in high-risk prostate cancer: correlation with <sup>18</sup>F-FDG-PET/CT and clinical outcome.Prostate Cancer Prostatic Dis2020
32047296Alternative promoters control UGT2B17-dependent androgen catabolism in prostate cancer and its influence on progression.Br J Cancer2020
33299664Immune-focused multi-omics analysis of prostate cancer: leukocyte Ig-Like receptors are associated with disease progression.Oncoimmunology2020
30819787Factors Affecting Interindividual Variability of Hepatic UGT2B17 Protein Expression Examined Using a Novel Specific Monoclonal Antibody.Drug Metab Dispos2019
31591588Genome-wide germline correlates of the epigenetic landscape of prostate cancer.Nat Med2019
31018850Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate.Radiat Oncol2019
30735634Widespread and Functional RNA Circularization in Localized Prostate Cancer.Cell2019
29603326The impact of intraductal carcinoma of the prostate on the site and timing of recurrence and cancer-specific survival.Prostate2018
28068672Genomic hallmarks of localized, non-indolent prostate cancer.Nature2017
28511883A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies.Eur Urol2017
27815082Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate Tumors.Eur Urol2017
26215610The UGT2B28 Sex-steroid Inactivation Pathway Is a Regulator of Steroidogenesis and Modifies the Risk of Prostate Cancer Progression.Eur Urol2016
26645279Phase II Drug-Metabolizing Polymorphisms and Smoking Predict Recurrence of Non-Muscle-Invasive Bladder Cancer: A Gene-Smoking Interaction.Cancer Prev Res (Phila)2016
25731206Low level of the X-linked ribosomal protein S4 in human urothelial carcinomas is associated with a poor prognosis.Biomark Med2015
26070608Comparison of digital image analysis and visual scoring of KI-67 in prostate cancer prognosis after prostatectomy.Diagn Pathol2015
23574787High level of mature tumor-infiltrating dendritic cells predicts progression to muscle invasion in bladder cancer.Hum Pathol2013
21166751Improved cancer specific-survival in patients with carcinoma invading bladder muscle expressing cyclo-oxygenase-2.BJU Int2011
19193487Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapy.Eur Urol2009
19533752High frequency of MAGE-A4 and MAGE-A9 expression in high-risk bladder cancer.Int J Cancer2009
18058798Tissue factor expression correlates with disease-specific survival in patients with node-negative muscle-invasive bladder cancer.Int J Cancer2008
17873893Identification of PCA3 (DD3) in prostatic carcinoma by in situ hybridization.Mod Pathol2007
15026327Accelerated induction of bladder cancer in patched heterozygous mutant mice.Cancer Res2004
14743466Expression of p21 cell cycle protein is an independent predictor of response to salvage radiotherapy after radical prostatectomy.Prostate2004
14613000[The PATCHED/Sonic Hedgehog signalling pathway in superficial bladder cancer].Med Sci (Paris)2003
10952237Early perturbations in keratin and actin gene expression and fibrillar organisation in griseofulvin-fed mouse liver.J Hepatol2000
11810447Reduction of cytochemical ecto-ATPase activities in keratin 8-deficient FVB/N mouse livers.Med Electron Microsc1999
  • 1 - 35 of 35

Recommended Authors

Mandeep Takhar
GenomeDx Biosciences Inc.
Career Start Year 2010
Number of shared co-authors 18
Brian D Robinson
Sandra and Edward Meyer Cancer Center
Career Start Year 2008
Number of shared co-authors 15
Sungyong You
Cedars-Sinai Medical Center
Career Start Year 2008
Number of shared co-authors 6
Verena Sailer
Institute for Pathology, University Hospital Schleswig-Holstein
Career Start Year 2007
Number of shared co-authors 3
Cynthia Kuk
Mount Sinai Hospital, University of Toronto, University Health Network
Career Start Year 2007
Number of shared co-authors 9
Michelle R Downes
University of Toronto
Career Start Year 2006
Number of shared co-authors 16
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 14
Robert H Bell
University of British Columbia
Career Start Year 2004
Number of shared co-authors 10
Thorsten Schlomm
Charite - University Hospital Berlin
Career Start Year 2004
Number of shared co-authors 15
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 25
Ashley E Ross
Northwestern University
Career Start Year 2003
Number of shared co-authors 18
Christopher E Barbieri
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 4
Tarek A Bismar
University of Calgary Cumming School of Medicine, Rockyview General Hospital
Career Start Year 2002
Number of shared co-authors 19
Yuzhuo Wang
University of British Columbia
Career Start Year 2000
Number of shared co-authors 26
Jiaoti Huang
Duke University School of Medicine
Career Start Year 2000
Number of shared co-authors 16
Hayley C Whitaker
University College London
Career Start Year 1999
Number of shared co-authors 14
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 15
Feliksas Jankevicius
Clinic of Gastroenterology, Vilnius University
Career Start Year 1995
Number of shared co-authors 3
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 13
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
Marshall Scott Lucia
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 6
Mark A Rubin
University of Bern
Career Start Year 1990
Number of shared co-authors 25
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 14
Adrie van Bokhoven
University of Colorado Anschutz Medical Campus
Career Start Year 1988
Number of shared co-authors 1
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 10
Anders Bjartell
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 20
Beatrice S Knudsen
University of Utah
Career Start Year 1986
Number of shared co-authors 15
Massimo Loda
Weill Medical College of Cornell University
Career Start Year 1984
Number of shared co-authors 23
David M Berman
Queen's University
Career Start Year 1982
Number of shared co-authors 30
Lawrence D True
University of Washington School of Medicine
Career Start Year 1980
Number of shared co-authors 13

Collaborators

Yves Fradet
CHU de Quebec-Universite Laval
Co-authored papers 30
Louis Lacombe
CHU de Quebec-Universite Laval
Co-authored papers 22
Alain Bergeron
Centre de recherche sur le cancer de l'Universite Laval
Co-authored papers 19
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 16
Herv?? Brisson
Centre de recherche du Centre hospitalier universitaire de Quebec-Universite Laval
Co-authored papers 9
Dominique Trudel
Institut du cancer de Montreal
Co-authored papers 8
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 8
Paul C Boutros
University of California los angeles
Co-authored papers 8
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 7
Mich??le Orain
Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Universite Laval
Co-authored papers 7
Val??rie Picard
Centre de recherche du CHU de Quebec-Universite Laval
Co-authored papers 7
Robert G Bristow
University of Toronto
Co-authored papers 7
Fred Saad
University of Montreal Health Center
Co-authored papers 6
Roula Albadine
Centre hospitalier de l'Universite de Montreal
Co-authored papers 5
Mathieu Latour
Centre Hospitalier de l'Universite de Montreal
Co-authored papers 5
Julie Livingstone
University of California los angeles
Co-authored papers 5
Melvin L K Chua
National Cancer Centre Singapore
Co-authored papers 5
Andr?? Kougioumoutzakis
Centre de recherche du Centre hospitalier de l'Universite de Montreal
Co-authored papers 4
Nazim Benzerdjeb
Institut de Pathologie Multisite
Co-authored papers 4
Yu-Jia Shiah
Ontario Institute for Cancer Research
Co-authored papers 3
Vincent Huang
Ontario Institute for Cancer Research
Co-authored papers 3
Emilie Lalonde
University of Pennsylvania
Co-authored papers 3
Mirela Birlea
Centre de recherche du Centre hospitalier de l'Universite de Montreal
Co-authored papers 3
Alejandro Berlin
University of Toronto, Princess Margaret Cancer Centre
Co-authored papers 3
Neil E Fleshner
University of Toronto
Co-authored papers 3
Andr??e-Anne Grosset
Centre de Recherche du Centre Hospitalier de l'Universite de Montreal (CRCHUM)
Co-authored papers 3
Colin C Collins
University of British Columbia
Co-authored papers 3
Lawrence E Heisler
Ontario Institute for Cancer Research
Co-authored papers 3
Housheng Hansen He
Princess Margaret Cancer Center, University Health Network, University of Toronto
Co-authored papers 3
Alice Meng
Tufts University School of Medicine
Co-authored papers 3
Release 1.2